Bausch Health Companies Stock Working Capital
| BHC Stock | USD 7.00 0.01 0.14% |
Bausch Health Companies fundamentals help investors to digest information that contributes to Bausch Health's financial success or failures. It also enables traders to predict the movement of Bausch Stock. The fundamental analysis module provides a way to measure Bausch Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bausch Health stock.
Bausch |
Bausch Health Companies Company Working Capital Analysis
Bausch Health's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Bausch Health Working Capital | (978 M) |
Most of Bausch Health's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bausch Health Companies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, Bausch Health Companies has a Working Capital of (978 Million). This is 329.77% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The working capital for all United States stocks is 166.16% higher than that of the company.
Bausch Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bausch Health's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bausch Health could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics of similar companies.Bausch Health is currently under evaluation in working capital category among its peers.
Bausch Fundamentals
| Return On Equity | -23.05 | ||||
| Return On Asset | 0.0433 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 23.01 B | ||||
| Shares Outstanding | 367.93 M | ||||
| Shares Owned By Insiders | 11.31 % | ||||
| Shares Owned By Institutions | 70.94 % | ||||
| Number Of Shares Shorted | 6.45 M | ||||
| Price To Earning | 9.26 X | ||||
| Price To Book | 18.78 X | ||||
| Price To Sales | 0.27 X | ||||
| Revenue | 9.52 B | ||||
| Gross Profit | 6.84 B | ||||
| EBITDA | 1.55 B | ||||
| Net Income | (72 M) | ||||
| Cash And Equivalents | 564 M | ||||
| Cash Per Share | 1.34 X | ||||
| Total Debt | 2.67 B | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | (3.48) X | ||||
| Cash Flow From Operations | 1.6 B | ||||
| Short Ratio | 2.06 X | ||||
| Earnings Per Share | (0.13) X | ||||
| Price To Earnings To Growth | 0.63 X | ||||
| Target Price | 8.67 | ||||
| Number Of Employees | 20.7 K | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 2.58 B | ||||
| Total Asset | 26.52 B | ||||
| Retained Earnings | (9.82 B) | ||||
| Working Capital | (978 M) | ||||
| Current Asset | 984.02 M | ||||
| Current Liabilities | 730.59 M | ||||
| Net Asset | 26.52 B |
About Bausch Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bausch Health Companies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health Companies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out Bausch Health Piotroski F Score and Bausch Health Altman Z Score analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.